| HS Code | 171119 |
| Product Name | L-Arginine Methyl Ester Dihydrochloride |
| Chemical Formula | C7H16N4O2·2HCl |
| Molecular Weight | 261.15 g/mol |
| Cas Number | 26340-89-6 |
| Iupac Name | methyl (2S)-2-amino-5-[(diaminomethylidene)amino]pentanoate dihydrochloride |
| Synonyms | H-Arg-OMe·2HCl; L-arginine methyl ester dihydrochloride; methyl L-argininate dihydrochloride |
| Appearance | white crystalline powder |
| Solubility | soluble in water (up to 50 mg/mL), clear to slightly hazy |
| Purity | ≥98% (TLC) |
| Melting Point | 193-195 °C (dec.) |
| Storage Conditions | store at 2-8°C, protected from moisture |
As an accredited L-Arginine Methyl Ester Dihydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 25 g of L-Arginine Methyl Ester Dihydrochloride supplied in a sealed amber glass bottle with tamper-evident cap. |
| Container Loading (20′ FCL) | 20′ FCL: L-Arginine Methyl Ester Dihydrochloride loaded in 25kg fiber drums on pallets, securely stacked and lashed for safe transit. |
| Shipping | Ship L-Arginine Methyl Ester Dihydrochloride in sealed, moisture-resistant containers, protected from light and humidity. Store cool and dry, away from oxidizers and acids. Material may cause eye/skin irritation; use proper labeling and PPE. Not typically regulated as dangerous goods, but declare as non-hazardous chemical for air and sea transport. |
| Storage | Store L-Arginine Methyl Ester Dihydrochloride sealed in a tightly closed container, protected from light and moisture. For optimal stability, keep it desiccated and refrigerated at 2–8°C, with long-term storage ideally at –20°C. Allow the vial to equilibrate to room temperature before opening to prevent condensation and hydrolysis. |
| Shelf Life | Stable for up to 2 years when stored tightly sealed at -20°C, protected from moisture and light. |
In solution-phase synthesis of arginine-terminated ester fragments, L-arginine methyl ester dihydrochloride is treated as a C-terminal protected amino acid equivalent with an unprotected guanidine side chain. The solid is dissolved in anhydrous dimethylformamide or dimethyl sulfoxide before addition of 2.2–2.5 molar equivalents of N-methylmorpholine or N,N-diisopropylethylamine, because the hydrochloride counterion must be neutralised before the α-amine can attack an activated carboxyl component. Coupling with Nα-protected amino acids is conducted with carbodiimide/active ester systems, typically 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride plus 1-hydroxybenzotriazole in a 1.0:1.0:1.1 molar ratio relative to the incoming protected amino acid, or with uronium reagents such as N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate in the presence of 2.5–3.0 equivalents of N,N-diisopropylethylamine. The reaction temperature is maintained at 0–5 °C during reagent addition and the bulk pH is held between 7.5 and 8.5. Below pH 7.0, incomplete deprotonation leaves residual ammonium salt and reduces conversion; above pH 10.5, the methyl ester undergoes saponification and the deprotonated guanidine side chain consumes active ester to form N-acylguanidine impurities that are difficult to separate by preparative C18 chromatography. For fragment condensation of a protected peptide acid onto the methyl ester, pre-formed active esters in dichloromethane/dimethylformamide at −15 to −10 °C are preferred because racemisation at the α-carbon is less pronounced than in carbodiimide-mediated one-pot couplings. Published data comparing epimerisation rates for free-guanidine arginine esters across all common coupling reagents is limited, so process development laboratories typically compare at least three activation chemistries before scale-up. The resulting C-terminal ester fragments are analysed by reversed-phase HPLC using a polar-embedded C18 column and a phosphate buffer at pH 2.5, with high-resolution mass spectrometry confirming the molecular ion. After coupling, the reaction mixture is quenched with 5% w/v aqueous sodium chloride and extracted with ethyl acetate or dichloromethane. The organic phase is washed with 0.1 M hydrochloric acid to remove excess tertiary amine and then with 5% w/v sodium hydrogen carbonate, but the bicarbonate wash must be performed at 0–5 °C because the methyl ester is susceptible to base-catalysed hydrolysis. Residual water is removed with anhydrous magnesium sulfate before concentration under vacuum below 25 °C. The crude ester is stored as a hydrochloride salt under nitrogen at relative humidity below 60%; if the material is exposed above 60% relative humidity, hygroscopic gain reduces stoichiometric accuracy and can promote hydrolytic cleavage of the methyl ester during subsequent long-term stability studies.
| Test parameter | Method designation | Purpose in release testing |
| Assay | USP <621>, Ph. Eur. 2.2.29 | HPLC area-normalised purity against a reference standard |
| Specific rotation | USP <781>, Ph. Eur. 2.2.7 | Polarimetric confirmation of enantiomeric identity in aqueous solution |
| Chloride content | USP <221>, Ph. Eur. 2.2.20 | Argentometric or potentiometric titration of the dihydrochloride counterion |
| Loss on drying | USP <731> | Vacuum drying at 60 °C to constant weight |
| Residual solvents | USP <467> | Headspace gas chromatography for volatile manufacturing solvents |
| Heavy metals | USP <231>, Ph. Eur. 2.4.8 | Colorimetric limit test for metal contamination in released lots |
Lauroyl chloride and related saturated fatty acid chlorides react with the α-amine of L-arginine methyl ester to produce Nα-acyl-L-arginine methyl ester hydrochlorides, a sub-class of cationic amino acid surfactants. The dihydrochloride salt is dissolved in deionised water at 10–15 °C, and the fatty acid chloride is diluted in acetone or tetrahydrofuran for slow addition. Sodium hydroxide at 5 M is metered under pH control to maintain the aqueous phase at pH 8.5–9.5; the base demand is higher than that required for the neutral amino acid because acylation releases one additional equivalent of chloride from the methyl ester hydrochloride, and the guanidine side chain remains protonated throughout the pH range. If the pH falls below 7.5, acylation at the α-amine slows sharply; if the pH exceeds 10.5, fatty acid chloride hydrolysis and partial methyl ester saponification compete. During the two-phase reaction, moderate agitation is applied because high-shear mixing at the aqueous-organic interface can accelerate hydrolysis of the acid chloride without increasing acylation rate. The reaction vessel is equipped with a pH electrode and a dosing pump for sodium hydroxide, and the addition rate of the fatty acid chloride is controlled by the heat-transfer capacity of the jacket because the reaction is exothermic. In batch equipment with a jacket temperature of −5 °C, a temperature excursion above 15 °C in the reactor core indicates that the acid chloride addition rate exceeds the cooling capacity, and the resulting hot spot is associated with faster ester hydrolysis and the formation of fatty acid soaps. The acylated product is precipitated by adjusting the mixture to pH 4.0–4.5 and is recrystallised from ethanol-water to remove unreacted fatty acid. Residual solvent is measured by headspace gas chromatography before the surfactant is used in formulation trials. For the Nα-lauroyl derivative, surface tension reduction is measured by Du Noüy ring tensiometry under ISO 304, with at least eight concentration points across three decades of concentration to identify the surface tension plateau. The ethyl ester homologue is listed as E 243 in European Commission Regulation (EC) No 1333/2008 for food preservation, but the methyl ester is not automatically equivalent; it is used mainly in comparative structure-activity studies. Microbiological evaluation against Staphylococcus aureus and Escherichia coli is performed by broth microdilution according to CLSI M07, and minimum inhibitory concentrations are interpreted only with a comparator strain because inoculum density, medium composition, and counterion form shift the apparent activity.
Mixed-acid nitration of the guanidine side chain proceeds via a nitronium-ion pathway and is the standard route to Nω-nitro-L-arginine methyl ester hydrochloride, a non-selective nitric oxide synthase inhibitor used in endothelial and neuronal nitric oxide studies. The methyl ester dihydrochloride is introduced into a stirred mixture of fuming nitric acid and concentrated sulfuric acid at −10 to −5 °C; the ester survives the cold nitration medium because the α-ammonium group remains fully protonated and acid-catalysed methyl ester hydrolysis is suppressed at low temperature. Nitration requires temperature monitoring at the reactor wall and in the bulk liquid because the mixing enthalpy of sulfuric acid and the nitration exotherm can combine. The methyl ester should be added as a solid in small portions, with the addition rate limited so that the internal temperature does not rise above 0 °C. The reaction yields the Nω-nitro derivative with retention of the methyl ester handle; after controlled quench into ice-water, the resulting acidic solution is adjusted to pH 5.0–6.0 with ammonium hydroxide or sodium carbonate to precipitate the product. Inorganic salts are reduced by recrystallisation from water-methanol, and the product is dried in a vacuum oven at 40 °C to constant weight. In pharmacological studies, the compound inhibits neuronal, inducible, and endothelial nitric oxide synthases; its action is assessed in isolated aortic ring preparations by measuring the shift in acetylcholine-induced relaxation after preincubation with graded inhibitor concentrations. The absorbance maximum of the nitrated guanidine can be used for HPLC detection at 270 nm, but this wavelength is not specific enough for impure samples, and LC-MS with selected ion monitoring is used to confirm the molecular ion. Researchers working with L-arginine methyl ester dihydrochloride must clearly distinguish the starting material from the nitrated product, because only the Nω-nitro derivative is pharmacologically active as a nitric oxide synthase inhibitor. Published in vivo dose-response data for L-NAME are highly variable across species and route of administration; therefore no single dose range can be transferred from one model to another without independent calibration. The nitrated methyl ester is handled as a tool compound and is not considered an approved drug substance.
Nα-Benzoyl-L-arginine methyl ester and Nα-tosyl-L-arginine methyl ester are prepared from L-arginine methyl ester dihydrochloride because trypsin recognition requires an acyl group on the α-amine; the free methyl ester is a poor substrate for bovine pancreatic trypsin. Benzoyl chloride is added dropwise to an aqueous solution of the dihydrochloride at pH 8.0–9.0 and 0–5 °C to produce Nα-benzoyl-L-arginine methyl ester hydrochloride, isolated by crystallisation. The benzoyl chloride used for substrate synthesis must be distilled before use because benzoyl chloride decomposition products consume the arginine starting material and lower the yield. In activity assays, trypsin cleaves the Nα-acyl-L-arginine methyl ester at the ester bond, releasing methanol and the corresponding Nα-acyl-L-arginine. Hydrolysis of Nα-benzoyl-L-arginine methyl ester is followed spectrophotometrically at 253 nm in a quartz cuvette thermostatted at 25 °C. A common assay mixture contains 0.1 M Tris-HCl buffer at pH 7.8, 10 mM calcium chloride, and 0.25 mM substrate; one unit of trypsin activity is conventionally defined as the amount of enzyme that hydrolyses 1 μmol of substrate per minute at pH 7.6 and 25 °C. Calcium chloride is included because trypsin is stabilised by calcium ions; omission of calcium chloride can reduce observed activity by 20–30% depending on the enzyme source and storage history. The linear initial increase in absorbance is converted to reaction velocity using the molar extinction coefficient of the Nα-benzoyl-L-arginine hydrolysis product. Assay linearity is limited because the absorbance change per unit time remains linear only until approximately 10% of the substrate is consumed; therefore the enzyme dilution is adjusted so that the initial rate is measured within the first 3–5 min. This substrate class is preferred in quality control laboratories because the methyl ester provides a chromogenic handle and because the synthetic route from L-arginine methyl ester dihydrochloride is straightforward. The isolated Nα-benzoyl-L-arginine methyl ester hydrochloride is stored at −20 °C under desiccation; storage at room temperature in open containers leads to hygroscopic gain and baseline drift in the spectrophotometric assay. The dihydrochloride starting material is therefore consumed as a synthetic precursor, not as a direct assay substrate, and the enzyme classification is EC 3.4.21.4.
The α-amine is reacted with methacryloyl chloride under biphasic conditions to produce Nα-methacryloyl-L-arginine methyl ester hydrochloride, a guanidinium-functionalised vinyl monomer. The methacrylamido monomer retains the methyl ester hydrochloride and can be copolymerised with 2-hydroxyethyl methacrylate or N-vinylpyrrolidone in dimethylformamide using 2,2′-azobis(2-methylpropionitrile) as initiator at 65 °C under nitrogen. Free radical polymerisation is conducted as a batch solution process; polymerisation conversion is tracked by proton NMR disappearance of the vinyl protons, with integration of the methacrylamide vinyl signals relative to an internal standard providing conversion data without relying solely on gravimetric yield. Reaction times of 18–24 h with initiator loadings of 1.0–2.0 mol% relative to total monomer are typical for batch solution polymerisation. The polymer is isolated by precipitation into diethyl ether or isopropanol and dried under vacuum at 35 °C. Molecular weight distribution is monitored by gel permeation chromatography with poly(methyl methacrylate) calibration, and residual monomer is quantified by reverse-phase HPLC. The resulting cationic polymer is coated onto glass or polyurethane substrates and examined as a contact-active antibacterial surface. For coating studies, the polymer is dissolved in methanol or water-methanol and applied to clean glass slides by dip coating, with the slide withdrawal speed controlling the dry coating thickness. Non-covalently adsorbed coatings may dissolve under repeated rinsing, so durability testing under simulated cleaning cycles is necessary before antimicrobial performance is reported. Dynamic contact activity is evaluated according to ASTM E2149-20, while cytotoxicity for biomedical uses is assessed in parallel according to ISO 10993-5. The mechanism of action involves electrostatic disruption of negatively charged bacterial phospholipid membranes; however, the same cationic density that increases antibacterial activity can also increase mammalian cytotoxic effects, so the charge density and copolymer composition require a narrow working window. Process data for continuous polymerisation of this specific methacrylamido monomer in twin-screw reactors or continuous stirred-tank trains has not been widely published, and scale-up is generally based on small-batch solution viscosity and initiator half-life calculations.
Competitive L-Arginine Methyl Ester Dihydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
L-Arginine methyl ester dihydrochloride, catalogued as L-Arg-OMe·2HCl or H-Arg-OMe·2HCl and registered under CAS 26340-89-6, is the C-terminal methyl ester of the proteinogenic amino acid L-arginine supplied as the stoichiometric dihydrochloride salt. The molecular formula is C7H16N4O2·2HCl and the relative molecular mass is 261.15. Commercial model and grade designations are supplier-specific rather than unified across the industry; common catalogue descriptors include L-arginine methyl ester dihydrochloride, peptide synthesis grade, H-Arg-OMe·2HCl, and L-Arg-OMe·2HCl. Two purity bands dominate routine supply: an organic synthesis grade controlled to ≥ 98.0% high-performance liquid chromatographic purity and a peptide synthesis grade controlled to ≥ 99.0% with additional limits on residual water and solvents. The theoretical hydrochloride content of the salt is 27.9%, and the theoretical free methyl ester content is 72.1%. The substance is supplied as a white to off-white crystalline powder in amber glass or double polyethylene packaging under nitrogen or argon headspace. Its established functions include selective N-acylation in solution-phase peptide assembly, preparation of Nω-substituted arginine derivatives, and use as an esterase or trypsin substrate in biochemical assays.
The selection between L-arginine methyl ester dihydrochloride and other arginine forms is determined by carboxyl-group availability, counterion stoichiometry, and the intended chemical transformation. L-Arginine free base retains a carboxylate group and behaves as a strongly basic zwitterion in aqueous solution. L-Arginine monohydrochloride also carries a free carboxyl group and is used predominantly as a pharmaceutical or feed-grade amino acid source. The methyl ester dihydrochloride, by contrast, has the terminal carboxylic acid blocked as an ester, which prevents zwitterion formation and enables solubility in polar organic solvents after neutralization of the hydrochloride salt. The ethyl ester dihydrochloride provides the same C-terminal protection but releases ethanol upon ester hydrolysis, whereas the methyl ester releases methanol, which is more readily removed under reduced pressure in downstream evaporative workup.
| Attribute | L-Arginine methyl ester dihydrochloride | L-Arginine free base | L-Arginine monohydrochloride | L-Arginine ethyl ester dihydrochloride |
|---|---|---|---|---|
| CAS registry | 26340-89-6 | 74-79-3 | 1119-34-2 | 36589-29-4 |
| Molecular formula | C7H16N4O2·2HCl | C6H14N4O2 | C6H14N4O2·HCl | C8H18N4O2·2HCl |
| Relative molecular mass | 261.15 | 174.20 | 210.66 | 275.17 |
| Counterion equivalents | 2 HCl | none | 1 HCl | 2 HCl |
| Typical aqueous pH | 2.0–3.0 for a 1% solution | 10.5–12.0 for a 5% solution | 5.5–7.0 for a 5% solution | 2.0–3.0 for a 1% solution |
| Key synthetic role | C-terminal protected arginine intermediate for selective N-acylation | Dietary supplement and basal arginine source | Pharmaceutical and feed-grade arginine source with defined single HCl content | C-terminal protected arginine with different ester hydrolysis kinetics |
The comparative values in the table are compiled from supplier certificates of analysis and safety data sheet ranges; individual lots may differ within the stated limits. The principal synthetic advantage of the methyl ester dihydrochloride is that the carboxyl terminus is protected, permitting regioselective reaction at the α-amino group after liberation of the free ester.
In a production-scale neutralization sequence, the dihydrochloride salt is charged to glass-lined or fluoropolymer-lined reactors containing anhydrous polar aprotic solvent. A 50 L jacketed reactor with bottom discharge and an external cooling loop is a common equipment configuration for pilot campaigns. The salt is suspended in N,N-dimethylformamide or dichloromethane and cooled to 0–5 °C. Tertiary amine, usually N,N-diisopropylethylamine, is added at a controlled rate to liberate the free amino methyl ester and form the corresponding tertiary amine hydrochloride. The neutralization is exothermic, and addition rate is controlled against the jacket temperature rather than by pH because the reaction medium is non-aqueous. Incomplete neutralization is a recurring batch-to-batch failure mode; it reduces acylation efficiency and can generate turbid reaction masses that pass only partially into the coupling step. In-process confirmation of primary amine liberation is performed by thin-layer chromatography with ninhydrin visualization or by a fluorescamine spot test. The reaction solvent is checked for water before neutralization because water above 0.05% promotes hydrolysis of the methyl ester during the hold time.
In solution-phase peptide coupling, the neutralized free amino methyl ester is acylated at the α-amino group while the guanidino side chain is either pre-protected as the 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl derivative or left unprotected only when reaction conditions tolerate a basic guanidine. Carbodiimide activation is carried out with N,N′-diisopropylcarbodiimide or N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride in the presence of 1-hydroxybenzotriazole. The coupling is typically initiated at 0–5 °C and then held at 15–25 °C for 16–24 h. Excess carbodiimide above 1.1 equivalents can promote N-acyl urea formation from the activated carboxyl component, and the charge is therefore controlled more tightly on scale-up than in bench demonstrations. Reverse-phase HPLC system suitability procedures follow USP 621, with peak purity evaluated at 210 nm because the arginine chromophore is weak.
The methyl ester dihydrochloride is not a direct substitute for Fmoc-Arg(Pbf)-OH in standard solid-phase peptide synthesis because the carboxyl terminus is blocked and the α-amino group is not protected as the fluorenylmethyloxycarbonyl derivative. Its use is therefore concentrated in solution-phase assembly, in the preparation of arginine-containing building blocks, and in the synthesis of arginine ester derivatives. After acylation, the methyl ester is removed under mild alkaline hydrolysis or by enzymatic cleavage. The liberated methanol is compatible with common solvent-recovery systems, which is a practical advantage over the ethyl ester when vacuum evaporation is used to concentrate the reaction mass.
Release specifications for a typical peptide synthesis grade lot include chromatographic purity of ≥ 99.0% by HPLC, water content by Karl Fischer titration per USP 921 of ≤ 0.5%, and sulfated ash of ≤ 0.1%. Specific rotation is reported on a dry basis; supplier certificates of analysis generally record [α]20D between +12.0° and +17.0° at c = 2 in water. Residual methanol is controlled below 3000 ppm because methanol is used or formed in the esterification step and is classified under ICH Q3C. Elemental impurities are evaluated by inductively coupled plasma mass spectrometry using the risk-based options of ICH Q3D. Published data for long-term stability of this specific ester under tropical conditions are limited; accelerated storage at 40 °C and 75% relative humidity should be treated as an internal screening condition rather than a regulatory stability claim.
The dihydrochloride salt is hygroscopic and must be kept in tightly sealed containers. Open containers should be stored in a desiccator over activated silica gel or molecular sieve at 15–25 °C. Exposure to relative humidity above 60% can produce surface wetting, caking, and measurable ester hydrolysis. The product is incompatible with strong oxidizing agents and with concentrated alkaline solutions; contact with sodium hydroxide hydrolyzes the methyl ester to L-arginine and methanol. Direct mechanical heating above 150 °C is avoided because decomposition releases hydrogen chloride and nitrogen oxides. Aqueous stock solutions prepared for biochemical use should be acidified to approximately pH 3.0–4.0 to suppress spontaneous ester hydrolysis. Published solution stability data for this specific configuration are limited, and storage intervals beyond 24 h at 2–8 °C must be confirmed by local analytical data before use.
In enzymatic work, the methyl ester is used as a substrate for trypsin-like proteases because the ester carbonyl remains susceptible to hydrolysis while the α-amino and guanidino groups are protonated in the dihydrochloride form. A stock solution of 10 mM in 1 mM hydrochloric acid is prepared to reduce spontaneous hydrolysis, and dilution into 50 mM Tris-HCl at pH 8.0 initiates the assay reaction. The release of L-arginine is followed by ninhydrin derivatization or by reverse-phase HPLC. The dihydrochloride is not a nitric oxide synthase inhibitor. That pharmacological activity belongs to Nω-nitro-L-arginine methyl ester hydrochloride, CAS 51298-62-5, which is a separate product with different substitution at the guanidino group. This distinction is critical in pharmacological protocols and in the ordering of arginine derivatives from chemical suppliers.